Upgrade to SI Premium - Free Trial

Arrowhead Pharmaceuticals Corp (ARWR) Appoints William Waddill to Board of Directors

December 27, 2017 4:00 PM
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors elected veteran biotechnology executive William Waddill as an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Management Changes Management Comments

Next Articles